MANKIND options
Mankind Pharma option chain and implied move
| Metric | Value | Read |
|---|---|---|
| Market-implied move | ±₹37.90 | ±1.71% to the Tuesday, 27 October 2026 expiry, from the at-the-money straddle |
| Implied range | ₹2,174.70 – ₹2,250.50 | What option prices imply, not a forecast of where the stock will trade |
| Max pain | ₹2,320 | The strike at which the largest value of written options would expire worthless |
| Heaviest put strike | ₹2,300 | 84,750 contracts — the largest put position on the chain |
| Heaviest call strike | ₹2,600 | 2,83,750 contracts — the largest call position on the chain |
| Put-call ratio | 0.47 | Total put open interest divided by total call open interest across the chain |
| Implied volatility (ATM) | 21.24% | At-the-money implied volatility for the front expiry |
- Market-implied move
- ±₹37.90
- Implied range
- ₹2,175 – ₹2,251
- Max pain
- ₹2,320
- Implied volatility
- 21.24%
±1.71% over 4 days, from the ₹2,220 straddle
What option prices imply, not a forecast of where the stock will trade
₹107 above the close
At the money, for the front expiry
Implied rangeMax painLast close
Heaviest put ₹2,300Heaviest call ₹2,600ATM ₹2,220 · PCR 0.47
At the close on Friday, 23 October 2026, Mankind Pharma options were pricing a move of ±₹37.90 by the Tuesday, 27 October 2026 expiry — a range of ₹2,174.70 to ₹2,250.50 against a closing price of ₹2,212.60. The figure is the at-the-money straddle at the ₹2,220 strike, which is what the options market itself is charging for the move to expiry. It describes the price of that expectation, not a forecast MarketCue makes.
Max pain sits at ₹2,320, ₹107.40 above the closing price — the strike at which the largest value of written options would expire worthless. The heaviest put position on the chain is at ₹2,300 with 84,750 contracts, and the heaviest call position at ₹2,600 with 2,83,750 contracts. Open interest describes where positions have been built; it is not a commitment by anyone to defend a price.
At-the-money implied volatility was 21.24% for the Tuesday, 27 October 2026 expiry. Realised volatility for Mankind Pharma is not yet available for comparison.
This page is a record of where Mankind Pharma's chain finished on Friday, 23 October 2026, not a live feed — the next reading follows tomorrow's close. Figures are derived from the NSE option chain via Upstox; max pain, the implied move, put-call ratio and the volatility comparison are MarketCue's own calculations from that data. MarketCue is not a registered investment adviser, research analyst or broker under SEBI regulations, and nothing here is a recommendation to buy or sell any security.
Read the full MarketCue scoring methodology
Source: NSE option chain via Upstox. .
Frequently asked questions
- What move are Mankind Pharma options pricing this expiry?
- ±₹37.90, or 1.71%, giving a range of ₹2,174.70 to ₹2,250.50 by Tuesday, 27 October 2026. The figure is derived from the at-the-money straddle at the ₹2,220 strike.
- What is Mankind Pharma's max pain?
- ₹2,320 at the last close, against a closing price of ₹2,212.60. Max pain is the strike at which the largest value of written options would expire worthless.
- Where is support and resistance in the Mankind Pharma option chain?
- The largest put position sits at ₹2,300 with 84,750 contracts, and the largest call position at ₹2,600 with 2,83,750 contracts. Traders commonly read heavy open interest at a strike as a level, though open interest describes positioning rather than any commitment to defend a price.
- What is the lot size for Mankind Pharma options?
- 250 shares per lot, with strikes in steps of ₹20. At the implied move of ±₹37.90, one lot corresponds to ±₹9,475 of notional movement.